Task: Answer the multiple choice question.
Query: Which drug exhibits a 11.914% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: O=C(CSc1ncccn1)NCc1ccc2c(c1)OCO2
b: Cn1c(NCC(O)c2ccccc2)nc2c1c(=O)n(Cc1ccc(Cl)c(Cl)c1)c(=O)n2C
c: CC(c1ccccc1)(c1ccccc1)c1ccncc1
Answer: a. O=C(CSc1ncccn1)NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1ncccn1)NCc1ccc2c(c1)OCO2
O=C(CSc1ncccn1)NCc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-ylmethyl)-2-pyrimidin-2-ylsulfanylacetamide